The effect of a Frequently Asked Questions module on a pancreatic cancer Web site patient/family chat roomJoAnn Coleman
Johns Hopkins Hospital, School of Nursing, Johns Hopkins University, Baltimore, MD 21287, USA
Cancer Nurs 28:460-8. 2005
..This study supported the addition of a FAQ module to a pancreatic cancer Web site and revealed the need for information regarding pain management and care giving at the end of life...
- Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors
Tom C Nguyen
Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-4606, USA
J Gastrointest Surg 7:1-9; discussion 9-11. 2003
..These results imply that no negative long-term QOL measures are associated with radical pancreaticoduodenectomy (as performed in this study) for periampullary adenocarcinoma...
- Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival
Taylor S Riall
Departments of Surgery, The Sol Goldman Pancreas Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
J Gastrointest Surg 9:1191-204; discussion 1204-6. 2005
..002)...
- Spiritual issues of family members in a pancreatic cancer chat room
Marie T Nolan
School of Nursing, Johns Hopkins University, Baltimore, MD, USA
Oncol Nurs Forum 33:239-44. 2006
..To describe spiritual issues addressed by users of a pancreatic cancer informational Web site...
- 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience
Jordan M Winter
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
J Gastrointest Surg 10:1199-210; discussion 1210-1. 2006
..This is the largest single-institution experience with PD for pancreatic cancer. Patients who have cancers with favorable pathological features have a statistically significant improved long-term survival...
- Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial
Jordan M Winter
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
J Gastrointest Surg 10:1280-90; discussion 1290. 2006
..3). Internal pancreatic duct stenting does not decrease the frequency or the severity of postoperative pancreatic fistulas...
- Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis
Jordan M Winter
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA
Ann Surg 243:673-80; discussion 680-3. 2006
....
- Hospital readmission after pancreaticoduodenectomy
Dawn M Emick
Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
J Gastrointest Surg 10:1243-52; discussion 1252-3. 2006
..The early hospital readmission rate has not increased in association with a decreased LOS, supporting the idea that reduction in LOS did not lead to increased readmission rates...
- One thousand consecutive pancreaticoduodenectomies
John L Cameron
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
Ann Surg 244:10-5. 2006
..To trace the evolution of pancreaticoduodenectomy from the decade of the 1960s through the first decade of the new Millenium, through the experience of one surgeon doing 1000 consecutive operations...
- Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer
Timothy M Pawlik
Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD, USA
Ann Surg Oncol 15:2081-8. 2008
..To evaluate the impact of a multidisciplinary clinic on the clinical care recommendations of patients with pancreatic cancer compared with the recommendations the patients received prior to review by the multidisciplinary tumor board...
- Cholecystectomy, liver resection, and pylorus-preserving pancreaticoduodenectomy for gallbladder cancer: report of five cases
John R Doty
Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
J Gastrointest Surg 6:776-80. 2002
..There is a select group of patients, however, in whom adding a pylorus-preserving pancreaticoduodenectomy can result in a potentially curative operation by removing extensive regional spread to the peripancreatic lymph nodes...
- Incidence and outcome of biliary strictures after pancreaticoduodenectomy
Michael G House
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
Ann Surg 243:571-6; discussion 576-8. 2006
..The development of a biliary stricture in patients who have undergone PD for malignant disease is usually benign and should not be automatically attributed to anastomotic tumor recurrence...
- Surgical management of bile duct injuries sustained during laparoscopic cholecystectomy: perioperative results in 200 patients
Jason K Sicklick
Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
Ann Surg 241:786-92; discussion 793-5. 2005
..Early referral to a tertiary care center with experienced hepatobiliary surgeons and skilled interventional radiologists would appear to be necessary to assure optimal results...
- Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality
Charles J Yeo
Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
Ann Surg 236:355-66; discussion 366-8. 2002
..To evaluate, in a prospective, randomized single-institution trial, the end points of operative morbidity, operative mortality, and survival in patients undergoing standard versus radical (extended) pancreaticoduodenectomy...
- Diagnostic laparoscopy for periampullary and pancreatic cancer: what is the true benefit?
Christopher J Barreiro
The Johns Hopkins Hospital, Johns Hopkins Medical Institutions, Baltimore, MD 21287-4603, USA
J Gastrointest Surg 6:75-81. 2002
..Of the 107 patients categorized as likely to be resectable, 89 were actually resected (83.2%). In contrast, only 10 of the 51 patients categorized as likely to be unresectable could be resected (19.6%)...
